December 2024

home / publications / directions-in-pharmacy / december-2024
Bispecific antibody -- Image credit: huenstructurebio.com | stock.adobe.com

Advancing Lung Cancer Treatment With Bispecific Antibodies: A Review of Amivantamab and Tarlatamab

Douglas Braun, PharmD, CSP, RPh
December 31st 2024
Article

Bispecific antibodies amivantamab and tarlatamab hold promise for patients.

Chronic lymphocytic leukemia -- Image credit: sovova | stock.adobe.com

Transforming CLL Management: Pharmacists’ Impact on Treatment Strategies, Adherence, and Quality of Life

December 30th 2024
Article

Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia.

Group of pharmacists -- Image credit: .shock | stock.adobe.com

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

Nicole Bentivegna, PharmD, BCOP;Gabriela Aponte-Melendez, PharmD;Natalie Kaufman, PharmD;Cooper Bailey, PharmD
December 27th 2024
Article

The program develops patient-centered oncology pharmacists through comprehensive training.

Multiple myeloma cells -- Image credit: Saiful52 | stock.adobe.com

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Amir Ali, PharmD, BCOP;Kevin Le, PharmD, BCOP;Tanjia Toma, PharmD Candidate;Soumar Haddad, PharmD Candidate;Fleuri Dindar, PharmD Candidate;Bryan Ceballos, PharmD Candidate
December 26th 2024
Article

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Patient receiving infusion treatment -- Image credit: Seventyfour | stock.adobe.com

Optimizing Infusion Chair Time for Oncology Trials: Follow-Up Study

Kaycey Pearce, PharmD;Jennifer Murphy, PharmD, BCOP, BCPS
December 25th 2024
Article

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Advocacy in Action: Opportunities for Oncology Pharmacists in 2025

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
December 24th 2024
Article

Pharmacists bring a unique perspective to health care that bridges clinical knowledge, patient-centered care, and operational expertise.

Multiple myeloma under microscope -- Image credit: Saiful52 | stock.adobe.com

Advancements in Multiple Myeloma Therapies and Operational Insights in Oncology Clinical Trials

Mike Hennessy Jr, President and CEO
December 23rd 2024
Article

The treatment landscape for multiple myeloma continues to evolve.